TY  - JOUR
AU  - Teuwen, Laure-Anne
AU  - De Rooij, Laura P M H
AU  - Cuypers, Anne
AU  - Rohlenova, Katerina
AU  - Dumas, Sébastien J
AU  - García-Caballero, Melissa
AU  - Meta, Elda
AU  - Amersfoort, Jacob
AU  - Taverna, Federico
AU  - Becker, Lisa M
AU  - Veiga, Nuphar
AU  - Cantelmo, Anna Rita
AU  - Geldhof, Vincent
AU  - Conchinha, Nadine V
AU  - Kalucka, Joanna
AU  - Treps, Lucas
AU  - Conradi, Lena-Christin
AU  - Khan, Shawez
AU  - Karakach, Tobias K
AU  - Soenen, Stefaan
AU  - Vinckier, Stefan
AU  - Schoonjans, Luc
AU  - Eelen, Guy
AU  - Van Laere, Steven
AU  - Dewerchin, Mieke
AU  - Dirix, Luc
AU  - Mazzone, Massimiliano
AU  - Luo, Yonglun
AU  - Vermeulen, Peter
AU  - Carmeliet, Peter
PY  - 2021
DO  - 10.1016/j.celrep.2021.109253
UR  - https://hdl.handle.net/10668/27805
T2  - Cell reports
AB  - Tumor vessel co-option is poorly understood, yet it is a resistance mechanism against anti-angiogenic therapy (AAT). The heterogeneity of co-opted endothelial cells (ECs) and pericytes, co-opting cancer and myeloid cells in tumors growing via vessel...
LA  - en
KW  - anti-angiogenic therapy
KW  - cancer cells
KW  - endothelial cells
KW  - macrophages
KW  - metastasis
KW  - pericytes
KW  - resistance
KW  - single-cell RNA sequencing
KW  - tumor angiogenesis
KW  - tumor vessel co-option
KW  - Animals
KW  - Cell Line, Tumor
KW  - Endothelial Cells
KW  - Female
KW  - Kidney Neoplasms
KW  - Lung Neoplasms
KW  - Macrophages
KW  - Mice, Inbred BALB C
KW  - Myeloid Cells
KW  - Neoplasms
KW  - Pericytes
KW  - Single-Cell Analysis
TI  - Tumor vessel co-option probed by single-cell analysis.
TY  - research article
VL  - 35
ER  -